How to Buy Novavax Stock
Novavax Inc
Novavax, Inc. , a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs.
Novavax stock last closed at $6.91, up 0.73% from the previous day, and has decreased 16.75% in one year. It has overperformed other stocks in the Biotechnology industry by 0.3 percentage points. Novavax stock is currently +37.92% from its 52-week low of $5.01, and -40.17% from its 52-week high of $11.55.
At the moment, there are 162.5M shares of NVAX outstanding. The market capitalization of NVAX is $1.12B. In the past 24 hours, 3.72M NVAX shares were traded.
How to Buy Novavax Stock
Not sure how to invest in Novavax stock? Here's how.
- Choose where to buy Novavax stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Novavax stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your investment account: Choose your payment method and add your information.
- Analyze Novavax stock: The Novavax ticker symbol is NVAX. Is Novavax stock a good investment? Should you buy shares of NVAX? How do NVAX's underlying business fundamentals look? Do top analysts think Novavax is a good buy? Why has NVAX's stock price moved recently? (Hint: Our stock analysis website can help you decide if NVAX is a good stock to buy).
- Execute your NVAX buy order: Decide if you will purchase NVAX shares at the current market price or use a limit order to purchase NVAX stock at a particular price.
- Get key alerts regarding your investment in NVAX: Create a watchlist to watch your position in Novavax shares.
Step 1: Choose where to buy Novavax stock
You need a brokerage account to access the NASDAQ market and buy NVAX stock.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal info so you are able to buy NVAX today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to start your new trading account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've filled out your info on mobile trading apps, you can securely and quickly fund your account:
Watch this video walkthrough to see the process of depositing funds into your brokerage account.
Step 4: Analyze Novavax stock
After you have decided on the best place to buy Novavax stock, it's absolutely critical to analyze their stock prior to buying, so you truly comprehend the risk as well as the opportunity.
Novavax stock data
NVAX Due Diligence Checks
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on NVAX's stock page.
Is NVAX stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NVAX's fair value.
Using relative valuations ratios:
- NVAX could be undervalued based on its P/E ratio of 3.27x, relative to Biotechnology industry P/E ratio of 186.51x
You can do additional valuation research on NVAX's stock here.
NVAX Financial Health
Pros:
- NVAX has cash burn of 384714000. It has enough cash and short-term investments to cover this for at least one year.
- NVAX profit margin has gone up from -32.2% to 32.1% in the past year.
- There are more short-term assets than short-term liabilities on the NVAX balance sheet.
- NVAX has $773.71M in cash and short term investments. This is enough to cover its annual cash burn of $384.71M.
- There are more short-term assets than long-term liabilities on the NVAX balance sheet.
Cons:
- NVAX debt to equity ratio of -8.53 is negative.
- Total NVAX debt is still negative.
Do analysts think it's a good time to buy NVAX stock
Out of 7 sell side analysts who monitor NVAX, the consensus analyst rating on NVAX is a Hold
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent NVAX Analyst Forecasts
Alec Stranahan, a bottom 2% analyst from Bank of America downgrades NVAX to a sell rating and lowers their NVAX price target from $9.00 to $7.00, on Aug 20, 2025.
Geoff Meacham, a top 12% analyst from Citigroup initiates coverage on NVAX with a strong sell rating and announces their NVAX price target of $6.00, on Jun 17, 2025.
You can dive deeper into what analysts are saying on the Novavax stock forecast page.
NVAX Momentum
Is NVAX Making Money?
Last year, NVAX revenue was $1.06B. During the past five year, NVAX's revenue has grown by 39.06% per year. This was slower than the Biotechnology industry average of 44.12%.
You can research NVAX's earnings and revenue performance here.
What are NVAX executives and large shareholders up to?
Over the past 12 months, executives and large shareholders at NVAX have sold more shares than they have bought.
Ruxandra Draghiaakli, Section 16 of NVAX, was the latest NVAX insider to sell. They sold $44,755.20 worth of NVAX shares on Nov 11, 2025.
Research more about who owns NVAX stock here.
Does NVAX stock generate passive income?
No, Novavax doesn't provide an income stream by paying out dividends.
What others are saying about NVAX
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your NVAX buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount limit, use a limit order.
Press the Open Trade button and your broker will execute your order.
If you need additional assistance buying stocks on eToro, watch the helpful video below:
Step 6: Get key alerts regarding your investment in NVAX
Now that you own some shares in NVAX, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to see the latest developments about your NVAX stock.
NVAX Feed
How to Buy Stock in Novavax
To summarize, here are the 6 steps to buy stock in Novavax:
- Choose where to buy Novavax stock
- Create your brokerage account
- Fund your investment account
- Analyze Novavax stock
- Execute your NVAX buy order
- Get key alerts regarding your investment in NVAX
If you need a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get updates on your investment in Novavax, create a watchlist today.
Other Articles You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.